Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses (as Wegovy), for weight management in adults with obesity
If you are on combination therapy, doses of existing medications may need to be increased
By combining the effects of reduced hunger, fewer cravings, and better blood sugar control, semaglutide can be a game-changer for those looking to lose weight, especially when paired with a healthy diet and regular physical activity
Davila HH, Magee TR, Zuniga FI et al: Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque
Read More HealthFeed Nov 03, 2025 Kratom: What You Need to Know About This Natural Opioid Kratom is a plant that comes from Southeast Asia that has opioid-like properties
As founding attorney Jon C